WO1999058641A8 - Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors - Google Patents

Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors

Info

Publication number
WO1999058641A8
WO1999058641A8 PCT/US1999/010311 US9910311W WO9958641A8 WO 1999058641 A8 WO1999058641 A8 WO 1999058641A8 US 9910311 W US9910311 W US 9910311W WO 9958641 A8 WO9958641 A8 WO 9958641A8
Authority
WO
WIPO (PCT)
Prior art keywords
nt2lp
protein
methods
gene
receptors
Prior art date
Application number
PCT/US1999/010311
Other languages
French (fr)
Other versions
WO1999058641A2 (en
Inventor
Rory Curtis
Maria Alexandra Glucksmann
Original Assignee
Millennium Pharm Inc
Rory Curtis
Maria Alexandra Glucksmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc, Rory Curtis, Maria Alexandra Glucksmann filed Critical Millennium Pharm Inc
Priority to AU38976/99A priority Critical patent/AU3897699A/en
Priority to EP99921872A priority patent/EP1078040A4/en
Priority to JP2000548434A priority patent/JP2003525576A/en
Priority to CA002327548A priority patent/CA2327548A1/en
Publication of WO1999058641A2 publication Critical patent/WO1999058641A2/en
Publication of WO1999058641A8 publication Critical patent/WO1999058641A8/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Abstract

The present invention is based on the identification of a novel G-protein coupled receptor (GPCR) that is expressed predominantly in the brain and nucleic acid molecules that encoded the GPCR, referred to herein as the NT2LP protein and NT2LP gene respectively. The NT2LP protein has high sequence homology to the NT family of receptors, particularly members of the NT2 subfamily. Based on this identification, the present invention provides: 1) isolated NT2LP protein, 2) isolated nucleic acid molecules that encode a NT2LP protein, 3) antibodies that selectively bind to the NT2LP protein, 4) methods of isolating allelic variants of the NT2LP protein and gene, 5) methods of identifying cells and tissues that express the NT2LP protein/gene, 6) methods of identifying agents and cellular compounds that bind to the NT2LP protein, 7) methods of identifying agents that modulate the expression of the NT2LP gene, 8) methods of modulating the activity of the NT2LP protein in a cell or organism and 9) a method for treating diseases, pathologies, or biological processes, for example, pain, comprising administering an agent that binds to and/or modulates NT2LP proteins.
PCT/US1999/010311 1998-05-11 1999-05-11 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors WO1999058641A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU38976/99A AU3897699A (en) 1998-05-11 1999-05-11 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors
EP99921872A EP1078040A4 (en) 1998-05-11 1999-05-11 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors
JP2000548434A JP2003525576A (en) 1998-05-11 1999-05-11 NT2LP, a novel G protein-coupled receptor having homology to the neurotensin-2 receptor
CA002327548A CA2327548A1 (en) 1998-05-11 1999-05-11 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US7631398A 1998-05-11 1998-05-11
US09/076,313 1998-05-11
US22349298A 1998-12-30 1998-12-30
US09/223,492 1998-12-30

Publications (2)

Publication Number Publication Date
WO1999058641A2 WO1999058641A2 (en) 1999-11-18
WO1999058641A8 true WO1999058641A8 (en) 2000-01-20

Family

ID=26757952

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/010311 WO1999058641A2 (en) 1998-05-11 1999-05-11 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors

Country Status (5)

Country Link
EP (1) EP1078040A4 (en)
JP (1) JP2003525576A (en)
AU (1) AU3897699A (en)
CA (1) CA2327548A1 (en)
WO (1) WO1999058641A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4551401A (en) * 2000-03-08 2001-09-17 Upjohn Co Novel g protein-coupled receptors
WO2001090149A2 (en) * 2000-05-22 2001-11-29 Pharmacia & Upjohn Company G protein-coupled receptors

Also Published As

Publication number Publication date
AU3897699A (en) 1999-11-29
WO1999058641A2 (en) 1999-11-18
JP2003525576A (en) 2003-09-02
EP1078040A4 (en) 2003-01-02
EP1078040A1 (en) 2001-02-28
CA2327548A1 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
NZ323795A (en) Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides
AU2560599A (en) Diagnosis and treatment of aur1 and/or aur2 related disorders
HUP0003533A2 (en) Interleukin-18 binding proteins, their preparation and use
DE69737740D1 (en) GDP dissociation stimulating protein, brain specific nucleosome joining protein, skeletal muscle specific ubiquitin conjugation enzyme, cell proliferation protein, phosphatidylinositol kinase, Nel related proteins
IS2361B (en) Ret ligament to stimulate nerve growth and urinary tract growth
WO1998031818A3 (en) Tace-like and matrilysin-like polypeptides
Presland et al. Characterization of two distinct calcium-binding sites in the amino-terminus of human profilaggrin
EP1717315A3 (en) Osteoprotegerin binding proteins and receptors
WO1995009872B1 (en) Dna encoding prostaglandin receptor ip
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
WO1998014596A3 (en) Disease associated protein tyrosine phosphatases
EP1281717A3 (en) Putative ion channel
RS92704A (en) Immunoglobulin-domain containing cell surface recognition molecules
WO1998011234A3 (en) Human protein kinases
WO1999058641A8 (en) Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors
ATE331032T1 (en) GLUTAMINE: FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE (GFAT), THEIR PRODUCTION AND USE
WO1998025956A3 (en) Human GTP-binding proteins
WO2000005373A9 (en) Methods and compositions for the diagnosis and treatment of body weight disorders, including obesity
Friedman et al. Reactions of proteins with ethyl vinyl sulfone
WO2003088910A3 (en) Methods of assaying for cell cycle modulators
IL122884A0 (en) Enamel matrix related polypeptide
WO2001042285A3 (en) Extracellular matrix and cell adhesion proteins as well as genes encoding them
MXPA03011260A (en) A g-protein coupled receptor and uses therefor.
WO1998031805A3 (en) Human zinc binding proteins
WO2004052233A3 (en) Canine rankl and methods for preparing and using the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

D17 Declaration under article 17(2)a
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 38976/99

Country of ref document: AU

ENP Entry into the national phase in:

Ref country code: CA

Ref document number: 2327548

Kind code of ref document: A

Format of ref document f/p: F

Ref document number: 2327548

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PA/a/2000/011048

Country of ref document: MX

NENP Non-entry into the national phase in:

Ref country code: KR

ENP Entry into the national phase in:

Ref country code: JP

Ref document number: 2000 548434

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999921872

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999921872

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999921872

Country of ref document: EP